Cuatrecasas is a leading Iberian law firm with its main offices in Portugal and Spain and international presence in 10
We are nearly 1.000 lawyers in 27 offices worldwide, organized by legal practice areas and multidisciplinary teams
with expertise in specific commercial and industrial sectors. In Portugal we have offices in Lisbon and Porto and a total of over 140 lawyers.
Our clients include companies in all commercial and industrial sectors, financial institutions, funds, supervisory
authorities and governmental entities and we have been involved in a large number of the most significant transactions executed in the markets where we have a presence, always committed to provide the highest-quality technical advice and client service.
We work with a new approach to client service, combining collective knowledge with innovation and the latest
technologies to offer contemporary, efficient advice and to provide solutions to the most complex situations, creating
value for the client, the team and the environment.
Our local teams in Beijing, Bogotá, Brussels, Casablanca, London, Luanda, Maputo, Mexico City, New York, São
Paulo and Shanghai and our international desks and over 20 country-specific groups, together with our associated
law firms in countries where we do not have offices, allow us to offer high standard advice in the context of the
international strategies of our clients.
Key legal info on biosimilars & biologics in Portugal. Prepared in association with Cuatrecasas, a leading Iberian law firm, this is an extract from The Pharma Legal Handbook: Portugal, available to purchase here for GBP 99. 1. Are biosimilar medicines considered the same as generic medicines in your country? Biosimilar medicines are defined by exclusion, i.e. a biosimilar medicine is a biological medicine which does not fulfil the conditions of the definition of a generic medicine (amongst other,…
Want to know more about localization in Portugal? Prepared in association with Cuatrecasas, a leading Iberian law firm, this is an extract from The Pharma Legal Handbook: Portugal, available to purchase here for GBP 99. 1. Are there any rules or regulations requiring and/or encouraging localization in your country? What is the legal framework defining these localization rules and policies? Generally, in the pharmaceutical sector, there are no rules and policies requiring localization in Portugal. However, it is…
An intro to the legal situation for orphan drugs and rare diseases in Portugal. Prepared in association with Cuatrecasas, a leading Iberian law firm, this is an extract from The Pharma Legal Handbook: Portugal, available to purchase here for GBP 99. 1. What is the definition of Rare Diseases in your country? There is no legal definition for Rare Disease within the national legislation. However, within the European Union, diseases that affect less than five in ten thousand…